Open access
Jul 2026
2-Oxoindoline-based hydroxamic acids: novel HDAC inhibitors with promising anticancer activity
Overall, 2-oxoindoline-based hydroxamic acids, particularly those bearing extended alkyl linkers, represent promising scaffolds for further development of HDAC-targeted anticancer agents.
Hương Thị Lan Trần, Hwa Kyung Kim, Thai Anh Tran Nguyen et al.
· RSC Advances · 0 citations